TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 NOK)
| Closing information | 2024/03 | 2023/03 | 2022/03 |
| Turnover |
98,438
|
88,258
|
77,461 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
13,495
|
12,669
|
6,284 |
| EBITDA |
13,572
|
12,833
|
6,491 |
| Total assets |
37,395
|
42,915
|
32,379 |
| Current assets |
37,238
|
42,698
|
32,052 |
| Current liabilities |
13,675
|
10,162
|
11,741 |
| Equity capital |
20,651
|
30,065
|
18,631 |
| - share capital |
102
|
100
|
93 |
| Employees (average) |
10
|
10
|
10 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Solvency |
55.2%
|
70.1%
|
57.5% |
| Turnover per employee |
9,844
|
8,826
|
7,746 |
| Profit as a percentage of turnover |
13.7%
|
14.4%
|
8.1% |
| Return on assets (ROA) |
36.1%
|
29.5%
|
19.4% |
| Current ratio |
272.3%
|
420.2%
|
273.0% |
| Return on equity (ROE) |
65.3%
|
42.1%
|
33.7% |
| Change turnover |
9,258
|
4,622
|
7,045 |
| Change turnover % |
10%
|
6%
|
10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.